Navigation Links
New antibiotic already developing resistance

An anti biotic, just a year old, which was developed to fight resistant bacteria, is already becoming stale as the bacteria are showing signs of resistance.

The drug linezolid is used to treat Enterococcus faecium (E. faecium) infections that are resistant to the old standby antibiotic vancomycin. The hope has been that the new drug would help tackle the growing problem of vancomycin-resistant enterococci infections. But in the April 14th issue of The Lancet, Chicago doctors report on five cases in which patients' infections became resistant to linezolid, as well.

Antibiotic resistance is a major problem worldwide, and hospitals are ground zero since infections and antibiotics are part of everyday life in these settings. Bacteria have an innate ability to mutate, and when they are repeatedly exposed to an antibiotic, they learn to change themselves in order to evade the drug. Bacteria that cause diseases such as pneumonia, tuberculosis and meningitis have learned to outsmart standard treatments. Without new drugs, experts fear some bacterial infections will become untreatable.

Before 1989, no US hospitals had experienced vancomycin-resistant E. faecium infections. By 1993, however, more than 10% of these infections acquired in hospitals were resistant to treatment. Linezolid was approved in April 2000 for the treatment of vancomycin-resistant E. faecium. Hence, doctors advice a sensitivity test before starting a patient on linezolid.
'"/>




Page: 1

Related medicine news :

1. Gene clue to antibiotics
2. Excessive use of antibiotics for sore throat
3. E. coli strains resistant to a common antibiotic
4. Cost-effective antibiotics for sinusitis treatment
5. Treatment of antibiotics ineffectual in bronchitis
6. Eczema patients lack natural antibiotic in skin
7. Modified antibiotic may support fight cancer
8. Vaccine Reduces antibiotic-resistant infections in Children
9. Use of antibiotics in farms may increase ‘super bugs
10. Frequent use of antibiotics raises the risk of carrying resistant infections
11. Novel antibiotic dressing developed for improved wound healing
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/25/2017)... , ... September 25, 2017 , ... Bobbie Horowitz was ... Osteoarthritis and multiple health issues. As a cabaret and theater producer, Horowitz would manage ... main source of transportation in New York City, so she had to take a ...
(Date:9/25/2017)... ... September 25, 2017 , ... Physician Partners of America ... at 5304 Main Street as an interventional pain management specialist. , Dr. Gorman ... He joins PPOA from private practice In Brooksville, Fla. His orthopedic background puts him ...
(Date:9/25/2017)... Charles, LA (PRWEB) , ... September 25, 2017 , ... ... in Lake Charles, LA. “I could not imagine doing anything else,” said Dr. Hebert. ... me each and every day. The interactions with my patients is what I look ...
(Date:9/25/2017)... ... September 25, 2017 , ... “The Majestic Unicorn”: a poignant ... “The Majestic Unicorn” is the creation of published author, Dayna Chantel, an artist and ... far and wide to march aboard the cypress ark-vessel. Male and female, no matter ...
(Date:9/25/2017)... VA (PRWEB) , ... September 25, 2017 , ... ... and Response Preconference Workshop, **Presented by FDAnews**, Nov. 1-3, 2017 – Bethesda, MD, ... drugmaker passed with flying colors. And then, on the tenth inspection it failed. ...
Breaking Medicine News(10 mins):
(Date:9/12/2017)... MOUNTAIN LAKES, N.J. , Sept. 12, 2017  Consumer reviews ... Embrace Hearing as the number one company for hearing ... Oticon™, ReSound™ and fifteen other brands. ... Embrace Hearing Named #1 by Consumers For Hearing Aids ... Embrace Hearing is an online store that ...
(Date:9/9/2017)... INDIANAPOLIS , Sept. 9, 2017  Eli Lilly ... key primary and secondary endpoint data for lasmiditan, an ... migraine, which demonstrated statistically significant improvements compared to placebo ... be highlighted today at the 18th Congress of the ... . "The data presented today demonstrate lasmiditan,s ...
(Date:9/7/2017)... STOCKHOLM , Sept. 7, 2017 NuvoAir ... Air Smart Spirometer, announced today a partnership with Novartis Pharma ... partnership solidifies NuvoAir,s position as the leading mobile spirometry platform ... respiratory patients. ... spirometry test ...
Breaking Medicine Technology: